Moderna Therapeutics
VerifiedProvides a real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease
Cambridge United States (HQ), Norwood United States
Deals in the last 12 months undisclosed
Company information
Edit Launch date
Employees
1,507 people
Ownership
Market cap
$49.3b
Net debt
$2.6b
Firm valuation
€37.5b (Public information from 2021)
| USD | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | 135m | 60m | 513m | 8.5b | 8.2b |
| % growth | - | - | - | (56 %) | 755 % | 1565 % | (4 %) |
| EBITDA | - | - | (388m) | (515m) | (479m) | 6.5b | 3.4b |
| % EBITDA margin | - | - | (287 %) | (858 %) | (93 %) | 76 % | 41 % |
| Profit | - | - | (402m) | (514m) | (560m) | 4.5b | 3.8b |
| % profit margin | - | - | (298 %) | (857 %) | (109 %) | 53 % | 46 % |
| EV / revenue | - | - | 32.6x | 92.1x | 91.0x | 4.8x | 4.6x |
| EV / EBITDA | - | - | -11.3x | -10.8x | -97.4x | 6.3x | 11.1x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| $20m | GRANT | ||
| N/A | $474m | GROWTH EQUITY | |
* | $500m Valuation: $7.5b | SERIES G | |
| $125m | SERIES H | ||
| N/A | $604m Valuation: $7.5b | IPO | |
| $430m | GRANT | ||
| $53m | GRANT | ||
| $472m | GRANT | ||
| $1.5b | GRANT | ||
| $1.7b | GRANT | ||
| Total Funding | €5.4b | ||
Recent News about Moderna Therapeutics
EditLists
